$0.859
-0.021 (-2.39%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GDTC por análisis de gráficos similares
Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.18%). The 1-week path is $0.84 (-2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CytoMed Therapeutics Ltd?
CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its poor financial performance and negative momentum indicators. The current price is $0.86, with a 52-week high of $2.29, indicating a significant drop of 62.4%. Additionally, the RSI is at 31.414, suggesting that the stock is oversold, but this does not guarantee a rebound. The gross margin has improved to 87.51%, but the company continues to report negative net income, with a loss of -885,226 SGD in the latest quarter. The main risk is the declining stock price, which has dropped 56.4% over the past year, indicating ongoing challenges for the company.
GDTC cerró en $0.86 el Friday, tras bajar -2.39%
CytoMed Therapeutics Ltd (GDTC) last closed at $0.859, losing -2.39%. These facts feed the 1-day and 1-week GDTC price prediction above.
Factores de la previsión
Los factores de la previsión de CytoMed Therapeutics Ltd (GDTC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GDTC, ordenadas por similitud.
Análisis de estacionalidad de GDTC
Historically the probability of a positive November return for GDTC is 0.00%. January offers the highest probability of a positive month at 4.92%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.